Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in  
Fiscal Period December 20152016201720182019
Sales19 65221 90322 38519 60019 500
EBITDA6 6217 300-5 8006 100
Operating profit (EBIT)6 1746 847---
Pre-Tax Profit (EBT)-----
Net income-68,0-16 525--
P/E ratio-----
EPS ( $ )-0,07-16,3--
Dividend per Share ( $ )1,361,36---
Yield-----
Reference price ( $ )23.347923.3479
Announcement Date02/11/2016
12:00pm
02/13/2017
11:42am
02/08/2018
03:00pm
--
Finances - Leverage
Actuals in M $ Estimates in  
Fiscal Period December 20152016201720182019
Debt3 02234 81231 512--
Finance-----
Operating income (EBITDA)6 6217 300-5 8006 100
Leverage
(Debt/EBITDA)
0,46x4,77x---
Capital Expenditure772901874--
Book Value Per Share (BVPS)-32,8 $17,1 $--
Cash Flow per Share-5,12 $---
Announcement Date02/11/2016
12:00pm
02/13/2017
11:42am
02/08/2018
03:00pm
---
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 23 665 M$ -
Entreprise Value (EV) - 23 665 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS)
Capitalization / Revenue 1,21x 1,21x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) - -
operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) - -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   - -
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend